Biosyent Inc (BIOYF)
7.49
-0.13
(-1.71%)
USD |
OTCM |
Jun 28, 16:00
Biosyent Market Cap: 86.77M for June 28, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 28, 2024 | 86.77M |
| June 27, 2024 | 88.28M |
| June 26, 2024 | 88.28M |
| June 25, 2024 | 86.91M |
| June 24, 2024 | 88.28M |
| June 21, 2024 | 85.15M |
| June 20, 2024 | 83.30M |
| June 18, 2024 | 81.68M |
| June 17, 2024 | 80.29M |
| June 14, 2024 | 81.10M |
| June 13, 2024 | 78.78M |
| June 12, 2024 | 79.36M |
| June 11, 2024 | 77.50M |
| June 10, 2024 | 77.50M |
| June 07, 2024 | 77.50M |
| June 06, 2024 | 77.39M |
| June 05, 2024 | 77.22M |
| June 04, 2024 | 77.22M |
| June 03, 2024 | 77.22M |
| May 31, 2024 | 77.16M |
| May 30, 2024 | 76.89M |
| May 29, 2024 | 76.69M |
| May 28, 2024 | 80.63M |
| May 24, 2024 | 76.35M |
| May 23, 2024 | 75.88M |
| Date | Value |
|---|---|
| May 22, 2024 | 75.88M |
| May 21, 2024 | 76.69M |
| May 20, 2024 | 81.10M |
| May 17, 2024 | 77.39M |
| May 16, 2024 | 72.52M |
| May 15, 2024 | 72.45M |
| May 14, 2024 | 71.29M |
| May 13, 2024 | 73.38M |
| May 10, 2024 | 73.38M |
| May 09, 2024 | 73.38M |
| May 08, 2024 | 73.46M |
| May 07, 2024 | 73.46M |
| May 06, 2024 | 73.46M |
| May 03, 2024 | 73.93M |
| May 02, 2024 | 73.45M |
| May 01, 2024 | 73.45M |
| April 30, 2024 | 73.35M |
| April 29, 2024 | 73.46M |
| April 26, 2024 | 72.88M |
| April 25, 2024 | 72.88M |
| April 24, 2024 | 72.88M |
| April 23, 2024 | 72.88M |
| April 22, 2024 | 72.91M |
| April 19, 2024 | 72.64M |
| April 18, 2024 | 72.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.84M
Minimum
Mar 18 2020
97.98M
Maximum
Jun 24 2021
69.78M
Average
70.78M
Median
Market Cap Benchmarks
| Acasti Pharma Inc | 27.45M |
| Aurinia Pharmaceuticals Inc | 813.78M |
| Edesa Biotech Inc | 13.76M |
| Lexaria Bioscience Corp | 35.90M |
| Xenon Pharmaceuticals Inc | 2.949B |
Market Cap Related Metrics
| PE Ratio | 17.23 |
| PS Ratio | 3.709 |
| PEG Ratio | 0.4082 |
| Price to Book Value | 3.393 |
| Price to Free Cash Flow | 17.37 |
| Price | 7.49 |
| Earnings Yield | 5.80% |
| PEGY Ratio | 0.3927 |
| Operating PE Ratio | 14.89 |
| Normalized PE Ratio | 17.21 |